University of California San Francisco

Human papillomavirus and survival of patients with oropharyngeal cancer.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML PMID: 20530316

Solitary fibrous tumor of the head and neck.

Cox DP, Daniels T, Jordan RC PMID: 20488732

Patterns of second-opinion diagnosis in oral and maxillofacial pathology.

Jones K, Jordan RC PMID: 20304686

In vitro study of the soft tissue effects of microsecond-pulsed CO(2) laser parameters during soft tissue incision and sulcular debridement.

Vaderhobli RM, White JM, Le C, Ho S, Jordan R PMID: 20333737

Mantle cell lymphoma of the oral cavity: case series and comprehensive review of the literature.

Guggisberg K, Jordan RC PMID: 19880332

Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program.

Feldman MD, Huang L, Guglielmo BJ, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS PMID: 19774102

Identification of novel fibroblast growth factor receptor 3 gene mutations in actinic cheilitis and squamous cell carcinoma of the lip.

Chou A, Dekker N, Jordan RC PMID: 19327639

Hyalinizing clear cell carcinoma: case series and comprehensive review of the literature.

Solar AA, Schmidt BL, Jordan RC PMID: 18980290

Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene.

Snijders AM, Huey B, Connelly ST, Roy R, Jordan RC, Schmidt BL, Albertson DG PMID: 19015636

Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).

Bjarnason GA, Mackenzie RG, Nabid A, Hodson ID, El-Sayed S, Grimard L, Brundage M, Wright J, Hay J, Ganguly P, Leong C, Wilson J, Jordan RC, Walker M, Tu D, Parulekar W, National Cancer Institute of Canada Clinical Trials Group (HN3) PMID: 18805649